Get startedLog in
    Picture of Kaken Pharmaceutical Co logo

    4521 — Kaken Pharmaceutical Co Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    HealthcareConservativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Kaken Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line26,59218,65713,8856,8179,796
    Depreciation
    Amortisation
    Non-Cash Items421-8242,5151,515-287
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-1,858-5,772-5,549-1,647-9,685
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities27,46714,37913,3379,2532,577
    Capital Expenditures-2,202-2,286-3,257-2,206-2,167
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-326642-4,631-421-3,687
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-2,528-1,644-7,888-2,627-5,854
    Financing Cash Flow Items—-1-1-1-1
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-10,173-8,752-8,129-6,990-5,658
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash14,7663,983-2,680-364-8,935